Events2Join

ASCO Pleased to See Cancer Research Prioritized in President ...


Every Award Tells a Story | Conquer Cancer, the ASCO Foundation

Conquer Cancer grants and awards support researchers throughout the span of their careers, enabling practice-changing discoveries that improve the lives of ...

Addressing Health Equity in Cancer Research and Treatment

Drs. Edith Perez, MD and Lori Pierce, MD discuss the importance of health equity, and the work SU2C and ASCO are doing to increase diversity ...

President's Cancer Panel Outlines Recommendations to Accelerate ...

The President's Cancer Panel has issued an initial assessment of the National Cancer Plan with recommendations to accelerate cancer care ...

BCRF Researcher Dr. Monica Bertagnolli Named 2018 ASCO ...

At the General Meeting of the American Society of Clinical Oncology (ASCO) in June, BCRF researcher, Dr. Monica Bertagnolli, was named as ...

COVID-19 & Cancer Patient Registry: Your Voice Matters

As ACCC President, Randall A. Oyer, MD, selected a theme for his year in office that addresses the serious imbalance in how clinical trials ...

History of the AACR | About Us

The American Association for Cancer Research was founded in 1907 at a propitious time. European scientific advances in the late 19th century had set the stage ...

Pfizer Highlights Progress in Accelerating Breakthrough Cancer ...

Pfizer Inc. (NYSE: PFE) highlights its progress in advancing new potential standards of care in Oncology at the 2024 American Society of Clinical Oncology ( ...

Janssen to Highlight Science, Innovation and Advances in Robust ...

Studies spanning industry-leading hematologic malignancies portfolio and pipeline with new research in solid tumor therapies to highlight precision medicine.

Cancer Care Report: Patient-centric, Evidence-based Medicine ...

“We also note that the report calls out pancreatic cancer and other of the deadliest cancers as those for which the rate of progress has not ...

Planning for the Nation: The President's Cancer Panel - NCI

In this episode of Inside Cancer Careers, we are joined by Dr. Elizabeth Jaffee, the current chair of the President's Cancer Panel, and Ms. Daniela Monterroza.

Fact Sheet: Quad Countries Launch Cancer Moonshot Initiative to ...

Today, the United States, Australia, India, and Japan are launching a groundbreaking effort to help end cancer as we know it in the ...

It's a wrap on ASCO 2024 - Owkin

Read key takeaways from ASCO from Ariane Peyret, our Discovery Solutions Manager, Pharma BD.

Fred Hutch at ASCO | Fred Hutchinson Cancer Center

Fred Hutch physician-researchers Drs. Julie Gralow, left, and Nancy E. Davidson were honored with ASCO's most prestigious awards for their leadership and ...

Meet The Professors Live: Clinical Investigators Provide ...

Faculty Floor J Backes, MD Professor Fellowship Director Division of Gynecologic Oncology Department of Obstetrics and Gynecology

ASCO Spotlight With Randall A. Oyer, MD: Clinical Trials Must Be ...

Randall A. Oyer, MD, medical director of the Ann B. Barshinger Cancer Institute, medical director of oncology, and medical director of the ...

WHAT THEY ARE SAYING: President Biden Reignites Cancer ...

... Cancer Network is extremely pleased to see that this Cancer Moonshot initiative prioritizes both health disparities and community input. Often, people think ...

Toni Choueiri's Post - President's Corner - LinkedIn

Can't miss the 2nd installment of President Robin Zon “President's Corner “ -It is a must read ! American Society of Clinical Oncology ...

ASCO names progress in rare cancer treatment 'Advance of the Year'

ASCO has named progress in treating rare cancers as the cancer Advance of the Year, recognizing major research advances that generated new ...

Treatment Sequencing in Advanced Kidney Cancer - News-Medical

Despite this, kidney cancers are the tenth most common cancer globally, with renal cell carcinoma (RCC) the most common type of kidney cancer, making up about ...

Third Annual Nixon National Cancer Conference Highlights How the ...

On January 17 and 18, 2024 more than 250 distinguished cancer center directors, executives, scientists, researchers, experts, academics, ...